Guillain-Barré syndrome

American Family Physician

Volumn 69, Issue 10, 2004, Pages 2405-2410

  Newswanger, Dana L ^a   Warren, Charles R ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NAVAL HOSPITAL JACKSONVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CORTICOSTEROID; GABAPENTIN; IMMUNOGLOBULIN; INFLUENZA VACCINE; NARCOTIC ANALGESIC AGENT;

ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONSULTATION; CROSS REACTION; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DYSAUTONOMIA; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION; MORTALITY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PARALYSIS; PLASMAPHERESIS; PROGNOSIS; REVIEW; SEDATION; SIDE EFFECT;

GUILLAIN-BARRE SYNDROME; HUMANS; PROGNOSIS; RECOVERY OF FUNCTION;

EID: 2442714037     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Lindenbaum Y, Kissel JT, Mendell JR. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Neuro Clin 2001;19:187-204.
2. Hahn AF. Guillain-Barré syndrome. Lancet 1998;352:635-41.
3. Seneviratne U. Guillain-Barré syndrome. Postgrad Med J 2000; 76:774-82.
4. Jiang GX, de Pedro-Cuesta J, Strigard K, Olsson T, Link H. Pregnancy and Guillain-Barré syndrome: a nationwide register cohort study. Neuroepidemiology 1996;15:192-200.
5. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group. Brain 1996;119(pt 6):2053-61.
6. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurology 2000;54:2311-5.
7. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-6.
8. Ropper AH, Shahani BT. Pain in Guillain-Barré syndrome. Arch Neurol 1984;41:511-4.
9. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4.
10. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001;58:913-7.
11. Jozefowicz RF. Neurologic diagnostic procedures. In: Goldman L, Bennett C, eds. Cecil textbook of medicine. 21st ed. Philadelphia: W.B. Saunders, 2000:2010-6.
12. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42.
13. Ho TW, Li CY, Cornblath DR, Gao CY, Asbury AK, Griffin JW, et al. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997;48:695-700.
14. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39:17-28.
15. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-6.
16. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 1994;17:1145-55.
17. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333:1374-9.
18. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, et al. Preceding infection, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001;56:758-65.
19. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998;339:1797-802.
20. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003;52:1-24.
21. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 2001;58:893-8.
22. Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Crit Care Med 2003;31:278-83.
23. Tripathi M, Kaushik S. Carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Crit Care Med 2000;28:655-8.
24. Pandey CK, Bose N, Garg G, Singh N, Baronia A, Agarwal A, et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blind, placebo-controlled, crossover study. Anesth Analg 2002;95:1719-23.
25. Van Der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992;326:1123-9.
26. Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;61:736-40.
27. Hughes RA, Raphaël JC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2004;(1):CD002063.
28. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Trial Group. Lancet 1997; 349:225-30.
29. Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barré syndrome. Crit Care Med 1993;21:443-46.
30. Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2004;(1):CD001798.
31. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Ann Neurol 1997;41:298-306.
32. Sater RA, Rostami A. Treatment of Guillain-Barré syndrome with intravenous immunoglobulin. Neurology 1998;51(6 suppl 5):S9-15.
33. Hughes RA, van Der Meche FGA. Corticosteroids for treating Guillain-Barré syndrome. Cochrane Database Syst Rev 2003;(4): CD001446. Review.
34. Lawn ND, Wijdicks EF. Fatal Guillain-Barré syndrome. Neurology 1999;52:635-8.